KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001860131-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
15,186
Total Value
$54,300.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 16, 2026 | Exercise/Conversion | 6,250 | โ | โ | 145,233 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 17, 2026 | Sale | 2,686 | $20.22 | $54,300.98 | 142,547 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Apr 16, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 93,750 | Direct | โ | View Details |